Efavirenz – Still First-line King?

Author： Best Brookie M   Goicoechea Miguel  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.7, 2008-07, pp. : 965-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lithium is still a first-line option in the treatment of patients with bipolar disorder

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 9-14

Adis International

Access to resources Recommend Favorite

Lithium for Older Adults with Bipolar Disorder: Should it Still be Considered a First-Line Agent?

By Shulman Kenneth I.  

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 607-615

Adis International

Access to resources Recommend Favorite

Adverse reactions to first-line antituberculosis drugs

By Forget Eric J   Menzies Dick  

Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. : 231-249

Informa Healthcare

Access to resources Recommend Favorite

Spironolactone "safer first-line" therapy for hypertension

By  

Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

-Blockers: "not appropriate" first-line therapy for hypertension

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite